Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Assessment of Ultrasound Findings, Nerve Test Results, and Hand Function in Patients With Carpal Tunnel Syndrome

13 de setembro de 2026 atualizado por: Hatice Zehra FERHATLAR, Kanuni Sultan Suleyman Training and Research Hospital

Association of Clinical Severity With Ultrasonographic, Electrophysiological, and Functional Parameters in Patients With Carpal Tunnel Syndrome: A Cross-Sectional Observational Study

Carpal tunnel syndrome is one of the most common conditions caused by compression of a nerve at the wrist. It can lead to numbness, tingling, pain, weakness, and difficulty performing daily activities. Although nerve conduction studies are widely used to confirm the diagnosis and assess disease severity, ultrasonography has become an increasingly important, non-invasive diagnostic tool. However, the relationship between ultrasound findings, nerve conduction study results, hand function, and symptom severity has not been fully clarified.

The purpose of this study is to investigate the relationship between the clinical severity of carpal tunnel syndrome and ultrasonographic, electrophysiological, and functional parameters. Participants with carpal tunnel syndrome will undergo ultrasonographic measurement of the median nerve, nerve conduction studies, hand grip strength assessment, pressure pain threshold measurement, and completion of the Boston Carpal Tunnel Questionnaire.

The investigators hypothesize that greater clinical severity will be associated with larger median nerve cross-sectional area, more severe electrophysiological abnormalities, reduced hand grip strength, lower pressure pain threshold, and poorer functional status. The findings of this study may improve the understanding of the relationship between structural, electrophysiological, and functional changes in carpal tunnel syndrome and contribute to clinical evaluation and patient management.

Visão geral do estudo

Tipo de estudo

Observacional

Inscrição (Real)

109

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Istanbul
      • Küçükçekmece, Istanbul, Turquia (Türkiye), 34307
        • Kanuni Sultan Suleyman Education and Research Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

N/D

Método de amostragem

Amostra Não Probabilística

População do estudo

The study population will consist of adult patients (≥18 years) with clinically suspected and electrophysiologically confirmed carpal tunnel syndrome who are evaluated in the Physical Medicine and Rehabilitation outpatient clinic. Participants will be classified into mild, moderate, and severe groups according to electrophysiological severity.

Descrição

Inclusion Criteria:

  • Adults aged 18 years or older
  • Clinical findings consistent with carpal tunnel syndrome
  • Carpal tunnel syndrome confirmed by electroneuromyography
  • Ability to understand and complete the study assessments
  • Provision of written informed consent

Exclusion Criteria:

  • Previous carpal tunnel release surgery
  • History of fracture, major trauma, or surgery involving the assessed wrist or hand
  • Cervical radiculopathy, brachial plexopathy, or other peripheral neuropathy affecting the upper extremity
  • Polyneuropathy
  • Inflammatory rheumatic disease or active infection involving the assessed upper extremity
  • Severe neurological or musculoskeletal disorder that may affect hand function
  • Inability to complete ultrasonographic, electrophysiological, functional, or questionnaire assessments

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

Coortes e Intervenções

Grupo / Coorte
Intervenção / Tratamento
Mild Carpal Tunnel Syndrome
Participants will undergo a standardized diagnostic assessment including ultrasonographic measurement of the median nerve cross-sectional area at the carpal tunnel inlet, nerve conduction study evaluation, hand grip strength measurement using a Jamar dynamometer, pressure pain threshold assessment using a digital algometer, and completion of the Boston Carpal Tunnel Questionnaire. All assessments will be performed once during a single study visit. No therapeutic intervention will be administered.
Moderate Carpal Tunnel Syndrome
Participants will undergo a standardized diagnostic assessment including ultrasonographic measurement of the median nerve cross-sectional area at the carpal tunnel inlet, nerve conduction study evaluation, hand grip strength measurement using a Jamar dynamometer, pressure pain threshold assessment using a digital algometer, and completion of the Boston Carpal Tunnel Questionnaire. All assessments will be performed once during a single study visit. No therapeutic intervention will be administered.
Severe Carpal Tunnel Syndrome
Participants will undergo a standardized diagnostic assessment including ultrasonographic measurement of the median nerve cross-sectional area at the carpal tunnel inlet, nerve conduction study evaluation, hand grip strength measurement using a Jamar dynamometer, pressure pain threshold assessment using a digital algometer, and completion of the Boston Carpal Tunnel Questionnaire. All assessments will be performed once during a single study visit. No therapeutic intervention will be administered.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Median Nerve Cross-Sectional Area Measured by Ultrasonography (mm²)
Prazo: Baseline (prior to study assessments, during the single study visit)
The median nerve cross-sectional area will be measured by high-resolution ultrasonography at the carpal tunnel inlet (pisiform level). The mean of three measurements will be recorded in square millimeters (mm²).
Baseline (prior to study assessments, during the single study visit)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Boston Carpal Tunnel Questionnaire Symptom Severity Score
Prazo: Baseline (prior to study assessments, during the single study visit)
Symptom severity will be assessed using the Boston Carpal Tunnel Questionnaire (BCTQ) Symptom Severity Scale. Scores range from 1 to 5, with higher scores indicating greater symptom severity.
Baseline (prior to study assessments, during the single study visit)
Boston Carpal Tunnel Questionnaire Functional Status Score
Prazo: Baseline (prior to study assessments, during the single study visit)
Functional status will be assessed using the Functional Status Scale of the Boston Carpal Tunnel Questionnaire (BCTQ-FSS). The questionnaire consists of 8 items evaluating difficulty in performing daily activities. Each item is scored from 1 (no difficulty) to 5 (cannot perform the activity), and the final score is calculated as the mean of all items. Higher scores indicate greater functional impairment.
Baseline (prior to study assessments, during the single study visit)
Hand Grip Strength Measured Using a Jamar Dynamometer (kg)
Prazo: Baseline (prior to study assessments, during the single study visit)
Maximum hand grip strength will be measured using a Jamar hydraulic hand dynamometer. The mean of three measurements will be recorded in kilograms (kg).
Baseline (prior to study assessments, during the single study visit)
Pressure Pain Threshold Measured Using a Digital Algometer (kPa)
Prazo: Baseline (prior to study assessments, during the single study visit)
Pressure pain threshold will be assessed using a digital pressure algometer. The mean of three measurements will be recorded in kPa
Baseline (prior to study assessments, during the single study visit)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de junho de 2026

Conclusão Primária (Real)

31 de julho de 2026

Conclusão do estudo (Real)

31 de julho de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

29 de julho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

3 de agosto de 2026

Primeira postagem (Real)

7 de agosto de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

16 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

13 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever